FDA Soliciting Broad Range of Comments From Industry on Regulatory Reform

Executive Summary FDA is addressing regulatory reform as part of President Trump's "two-for-one" executive order, and seeks industry comments to supplement the effort.

Executive Summary

FDA is addressing regulatory reform as part of President Trump's "two-for-one" executive order, and seeks industry comments to supplement the effort.

StacksOfPapers_1200x675
Source: pink.pharmamedtechbi.com